Rosiglitazone Plaque Study

NCT00123227 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Vascular Diseases
Hypertension

Interventions

DRUG: Rosiglitazone

Sponsor

Royal Brompton & Harefield NHS Foundation Trust

Collaborators

[object Object]
[object Object]